General Information
DRAVP ID DRAVPe00530
Peptide Name peptide 13
Sequence EAIIRILQELLFKHFRIGRRRRRRRR
Sequence Length 26
UniProt ID No entry found
Taxon ID None
Source Synthetic construct
Validation Experimentally Validated
Origin Information
Gene Name/ID Not Available
GenBank Not Available
Amino Acid position Not Available
Domain Accession ID Not Available
Nucleotide sequence ID Not Available
Molecular Type Not Available
Chromosomal Position Not available
Activity Information
Target Organism HIV
Assay Integrase assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target Integrase
Mechanism The peptide acts antiviral activity by inhibiting the activity of integrase.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe00530
Linear/Cyclic Linear
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C152H266N60O32
Absent amino acids CDMNPSTVWY
Common amino acids R
Mass 3446.17
Pl 12.37
Basic residues 12
Acidic residues 2
Hydrophobic residues 10
Net charge 10
Boman Index -13542
Hydrophobicity -100.77
Aliphatic Index 108.85
Half Life
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Literature Information
Literature 1
Title Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.
Pubmed ID 20708407
Reference Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.
Author Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.